BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25444225)

  • 1. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
    Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
    Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
    Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F
    World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
    Parfitt J; Harris M; Wright JM; Kalamchi S
    J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing.
    Koikawa K; Okada Y; Mori H; Kawaguchi M; Uchino S; Tanaka Y
    Intern Med; 2018 Mar; 57(6):841-844. PubMed ID: 29225260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CDC73 mutations in young patients with primary hyperparathyroidism: A description of two clinical cases].
    Mamedova EO; Mokrysheva NG; Pigarova EA; Przhiyalkovskaya EG; Voronkova IA; Vasilyev EV; Petrov VM; Gorbunova VA; Rozhinskaya LY; Belaya ZE; Tyulpakov AN
    Ter Arkh; 2016; 88(10):57-62. PubMed ID: 27801421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
    Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
    Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
    Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
    Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
    Iacobone M; Masi G; Barzon L; Porzionato A; Macchi V; Ciarleglio FA; Palù G; De Caro R; Viel G; Favia G
    Langenbecks Arch Surg; 2009 Sep; 394(5):817-25. PubMed ID: 19529956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.
    Guarnieri V; Seaberg RM; Kelly C; Jean Davidson M; Raphael S; Shuen AY; Baorda F; Palumbo O; Scillitani A; Hendy GN; Cole DEC
    BMC Med Genet; 2017 Aug; 18(1):83. PubMed ID: 28774260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family case report of parathyroid carcinoma associated with
    Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
    Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
    Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
    van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
    Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
    Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome.
    Bellido V; Larrañaga I; Guimón M; Martinez-Conde R; Eguia A; Perez de Nanclares G; Castaño L; Gaztambide S
    Endocr Pathol; 2016 Jun; 27(2):142-6. PubMed ID: 26995009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
    Tora R; Welch J; Sun J; Agarwal SK; Bell DA; Merino M; Weinstein LS; Simonds WF; Jha S
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3165-3177. PubMed ID: 37339334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyper Parathyroidisim Jaw Tumor Syndrome: A Rare Condition of Incongruous Features.
    Redwin Dhas MP; Karthiga KS; Tatu JE; Eugenia SJ
    Ethiop J Health Sci; 2017 May; 27(3):309-313. PubMed ID: 29217931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
    Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
    Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
    Cardoso L; Stevenson M; Thakker RV
    Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.